Effectiveness of Tocilizumab in Patients With Rheumatoid Arthritis is Unaffected by Comorbidity Burden or Obesity: Data From a US Registry.

CONCLUSION: In this real-world analysis, TCZ was frequently used to treat patients with high comorbidity burden or obesity. Effectiveness of TCZ did not differ by comorbidity or obesity status.
PMID: 31941801 [PubMed - as supplied by publisher]

Source: J Rheumatol - January 14, 2020 Category: Rheumatology Authors: Pappas DA, Etzel CJ, Crabtree M, Blachley T, Best J, Zlotnick S, Kremer JM Tags: J Rheumatol Source Type: research